Relative to benign tissue, ovarian tumors exhibited a striking 8.4-fold higher CS activity, 3.3-fold higher SDH activity, and a 8.2-fold higher COX activity (Fig. 2C), but a similar (3.1% lower, N.S.)mtDNAcn (Fig. 2D). The gene discussed is CS; the disease is ovarian neoplasm.